These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 26876764)
1. Impact of the digital revolution on the future of pharmaceutical formulation science. Leuenberger H; Leuenberger MN Eur J Pharm Sci; 2016 May; 87():100-11. PubMed ID: 26876764 [TBL] [Abstract][Full Text] [Related]
2. An attempt to calculate in silico disintegration time of tablets containing mefenamic acid, a low water-soluble drug. Kimura G; Puchkov M; Leuenberger H J Pharm Sci; 2013 Jul; 102(7):2166-78. PubMed ID: 23613462 [TBL] [Abstract][Full Text] [Related]
3. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium. Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351 [TBL] [Abstract][Full Text] [Related]
4. Review of bilayer tablet technology. Abebe A; Akseli I; Sprockel O; Kottala N; Cuitiño AM Int J Pharm; 2014 Jan; 461(1-2):549-58. PubMed ID: 24370841 [TBL] [Abstract][Full Text] [Related]
5. Use of a continuous twin screw granulation and drying system during formulation development and process optimization. Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462 [TBL] [Abstract][Full Text] [Related]
6. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution. von Orelli J; Leuenberger H Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920 [TBL] [Abstract][Full Text] [Related]
7. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium. Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650 [TBL] [Abstract][Full Text] [Related]
8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
9. Development of a high drug load tablet formulation based on assessment of powder manufacturability: moving towards quality by design. Sun CC; Hou H; Gao P; Ma C; Medina C; Alvarez FJ J Pharm Sci; 2009 Jan; 98(1):239-47. PubMed ID: 18428197 [TBL] [Abstract][Full Text] [Related]
10. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069 [TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
13. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations. Bejugam NK; Mutyam SK; Shankar GN Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424 [TBL] [Abstract][Full Text] [Related]
15. Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications. Tuomela A; Laaksonen T; Laru J; Antikainen O; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L Int J Pharm; 2015 May; 485(1-2):77-86. PubMed ID: 25746735 [TBL] [Abstract][Full Text] [Related]
16. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations. Giacoia GP; Taylor-Zapata P; Zajicek A Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008 [TBL] [Abstract][Full Text] [Related]
17. Optimization of a pharmaceutical tablet formulation based on a design space approach and using vibrational spectroscopy as PAT tool. Chavez PF; Lebrun P; Sacré PY; De Bleye C; Netchacovitch L; Cuypers S; Mantanus J; Motte H; Schubert M; Evrard B; Hubert P; Ziemons E Int J Pharm; 2015; 486(1-2):13-20. PubMed ID: 25791761 [TBL] [Abstract][Full Text] [Related]
18. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen]. Zimmer Ł; Kasperek R; Poleszak E Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904 [TBL] [Abstract][Full Text] [Related]
19. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095 [TBL] [Abstract][Full Text] [Related]
20. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac. Kambayashi A; Blume H; Dressman J Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]